In the run-up to the 2026 midterm elections, the political parties in many states are working to redefine their congressional district maps to gain every possible edge. From California and Texas to Tennessee and Virginia, redistricting efforts have taken center stage. The Supreme Court has sanctioned partisan gerrymandering, and the system has evolved to one in which state legislature majorities get to determine who is most likely to fill those seats in Congress.
In short, gerrymandering has become a central feature of the system, not a bug. But what if we rethink the structure entirely?
For years, remote work has been viewed as one of the most important drivers of employee satisfaction. New research suggests that assumption may be giving remote work too much credit.
A study published in the INFORMS journal Management Science found that while remote employees often report higher job satisfaction, much of that advantage disappears when researchers account for factors such as workplace culture, trust in management, communication and opportunities for professional development.
A new study from INFORMS suggests warehouse robots perform better when they work together instead of operating independently.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
CATONSVILLE, MD, January 12, 2021 – Machine learning and artificial intelligence (AI) are perfectly suited to help companies and marketers monitor and set prices based on real-time dynamic pricing. But new research has identified some possible unintended consequences of AI in this area.
Like certain celebrities, the “vaccine” does not need a first name or modifier. Data from both Pfizer and Moderna have shown their COVID-19 vaccines to be nearly 95% effective in preventing disease in people who received two doses, thus earning a green light from the Food and Drug Administration. Other vaccines in clinical trials also are showing promising results. Although vaccine doses have been distributed to all states, limited quantities will force states to prioritize those who should get the first doses.
The good news toward the end of 2020 was the emergency approval of two COVID-19 vaccines. Like certain celebrities, the “vaccine” did not need a first name or modifier. Everyone heard of the promising data coming out of Pfizer and Moderna, showing the vaccines to be about 95% effective against preventing COVID-19 in people who received two doses. Other vaccines also showed promising results, and the Food and Drug Administration has already given emergency use authorization (EUA) to the Pfizer and Moderna vaccines.
Many Americans and healthcare workers have doubts and skepticism about the first vaccines for COVID-19, despite the need for a rapid end to the pandemic surge that began to overflow hospitals before the December holidays. “The truth is that healthcare workers are not immune from vaccine hesitancy,” says Tinglong Dai, PhD, associate professor of operations management and business analytics at Johns Hopkins University Carey Business School in Baltimore. “It’s a phenomenon with real public health impacts.”
It was early Dec. 23 when 100 doses of the Moderna COVID-19 vaccine arrived in Baltimore County, and by evening half had been given to health department workers and half to first responders. About 3,400 more Moderna doses arrived a week later, and 6,825 Pfizer doses arrived after that. They have not all been used, though appointments are scheduled to use many of them. “People have to understand, I can’t now just open a clinic and hope I get vaccine,” said Dr. Gregory Branch, the county health officer. “I have to plan once I know how much vaccine I’m getting.”
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine